Home » Stocks » ICLR

ICON plc (ICLR)

Stock Price: $228.82 USD 5.70 (2.55%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 12.12B
Revenue (ttm) 2.80B
Net Income (ttm) 332.33M
Shares Out 52.86M
EPS (ttm) 6.35
PE Ratio 36.03
Forward PE 25.84
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $228.82
Previous Close $223.12
Change ($) 5.70
Change (%) 2.55%
Day's Open 222.12
Day's Range 220.57 - 230.97
Day's Volume 918,247
52-Week Range 151.54 - 230.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Icon PLC (ICLR) delivered earnings and revenue surprises of 6.74% and 9.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2021 Results

1 week ago - Business Wire

According to the GuruFocus discounted cash flow calculator as of April 21, the following companies have a high margin of safety and have grown their margins over a 10-year period.

Other stocks mentioned: AOS, CBOE, GRFS, MPW
2 weeks ago - GuruFocus

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) ICON plc, a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, has w...

2 weeks ago - Business Wire

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

Other stocks mentioned: ALGN, PRAH, STE, TDOC, TMO, XRAY
3 weeks ago - Zacks Investment Research

Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

3 weeks ago - Zacks Investment Research

The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with a ...

Other stocks mentioned: CHE, DVA, EBS, SEM
1 month ago - GuruFocus

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

1 month ago - Business Wire

Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

2 months ago - Zacks Investment Research

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PRA Health S...

Other stocks mentioned: PRAH
2 months ago - GlobeNewsWire

Icon PLC (ICLR) delivered earnings and revenue surprises of 3.83% and 1.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2020 Results

2 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research

Other stocks mentioned: PRAH
2 months ago - Business Wire

Icon (NASDAQ:ICLR) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

2 months ago - Benzinga

Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the rel...

3 months ago - Business Wire

Icon PLC (ICLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference

4 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device indus...

Other stocks mentioned: BNTX, PFE
4 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

6 months ago - Business Wire

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of 10.97% and 5.54%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of Icon (NASDAQ:ICLR) moved lower by 0.6% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 1.15% year over year to $1.72, which beat t...

6 months ago - Benzinga

DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device ind...

6 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries a...

7 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries a...

8 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference

8 months ago - Business Wire

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries today an...

8 months ago - Business Wire

ICON's (ICLR) CEO Steven Cutler on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of 9.09% and 4.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Shares of Icon (NASDAQ:ICLR) were unchanged after the company reported Q2 results.

9 months ago - Benzinga

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Wayfair stock benefited from the novel coronavirus and is up big year to date. It’s time to consider other stocks.

Other stocks mentioned: STRA, WDAY
11 months ago - InvestorPlace

ICON Public Limited Company (ICLR) CEO Dr. Steven Cutler on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

This week, we’re highlighting three stocks to buy that have been dragged down by the current market turmoil.

Other stocks mentioned: HD, TJX
1 year ago - Seeking Alpha

These stocks are for great companies whose valuations are a little high. As valuations decline, investors should scoop up these quality businesses.

Other stocks mentioned: HD, TJX
1 year ago - Forbes

ICON PLC (ICLR) CEO Steven Cutler on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and -1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Other stocks mentioned: CDNS, CRL, TTC
1 year ago - Zacks Investment Research

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

1 year ago - Zacks Investment Research

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

1 year ago - Zacks Investment Research

Iconix Brand Group, Inc. (ICON) CEO Bob Galvin on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

1 year ago - Zacks Investment Research

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.60% and 0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharm... [Read more...]

Industry
Diagnostics & Research
IPO Date
May 15, 1998
CEO
Stephen Cutler
Employees
16,070
Stock Exchange
NASDAQ
Ticker Symbol
ICLR
Full Company Profile

Financial Performance

In 2020, ICON plc's revenue was $2.80 billion, a decrease of -0.30% compared to the previous year's $2.81 billion. Earnings were $332.33 million, a decrease of -11.14%.

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for ICON plc stock is "Buy." The 12-month stock price forecast is 245.00, which is an increase of 7.07% from the latest price.

Price Target
$245.00
(7.07% upside)
Analyst Consensus: Buy